Skip to main content
PMC home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1988 Dec 15;139(12):1143–1151.

Cost-effectiveness of primary tetanus vaccination among elderly Canadians.

B G Hutchison 1, G L Stoddart 1
PMCID: PMC1268477  PMID: 3143478

Abstract

Although tetanus is now rare, vaccination is currently recommended for the entire population. Most elderly North Americans have never received tetanus vaccination. We evaluated the expected cost-effectiveness of using mailed reminders from family physicians to increase primary tetanus vaccination coverage among elderly Canadians. We estimated that over 10 years the program would prevent five cases of tetanus and one death from tetanus, resulting in a gain of 13 life-years. There would be 16,700 adverse reactions to tetanus toxoid, 17% in people already immune to tetanus. The net cost of the program (in 1984 Canadian dollars) would be $1.9 million per case of tetanus prevented, $7.1 million per death prevented and $810,000 per life-year gained. These high cost-effectiveness ratios are largely attributable to the very low risk of tetanus, even among nonimmune elderly people. Tetanus toxoid and physicians' services for vaccination would account for 86% of the program costs. Because the mailed reminders would be responsible for only 13% of the program costs, other possible programs to increase primary tetanus vaccination coverage could not be expected to have substantially lower cost-effectiveness ratios. We conclude that efforts to increase primary tetanus vaccination coverage among elderly Canadians would be a questionable use of health care resources.

Full text

PDF
1143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acres S. E., Varughese P. V. Impact of vaccination on selected diseases in Canada. Can Med Assoc J. 1985 Mar 15;132(6):635–639. [PMC free article] [PubMed] [Google Scholar]
  2. Collier L. H., Polakoff S., Mortimer J. Reactions and antibody responses to reinforcing doses of adsorbed and plain tetanus vaccines. Lancet. 1979 Jun 30;1(8131):1364–1368. doi: 10.1016/s0140-6736(79)92006-3. [DOI] [PubMed] [Google Scholar]
  3. Comstock George W., Brownlow Wilfred J., Joseph J. Mehsen, Garber Howard J. Validity of interview information in estimating community immunization levels. Health Serv Rep. 1973 Oct;88(8):750–757. [PMC free article] [PubMed] [Google Scholar]
  4. Crossley K., Irvine P., Warren J. B., Lee B. K., Mead K. Tetanus and diphtheria immunity in urban Minnesota adults. JAMA. 1979 Nov 23;242(21):2298–2300. [PubMed] [Google Scholar]
  5. Edsall G. Editorial: The inexcusable disease. JAMA. 1976 Jan 5;235(1):62–63. doi: 10.1001/jama.235.1.62. [DOI] [PubMed] [Google Scholar]
  6. Edsall G., Elliott M. W., Peebles T. C., Eldred M. C. Excessive use of tetanus toxoid boosters. JAMA. 1967 Oct 2;202(1):111–113. doi: 10.1001/jama.202.1.111. [DOI] [PubMed] [Google Scholar]
  7. Edsall G. Problems in the immunology and control of tetanus. Med J Aust. 1976 Aug 7;2(6):216–220. doi: 10.5694/j.1326-5377.1976.tb130113.x. [DOI] [PubMed] [Google Scholar]
  8. Fedson D. S. Influenza and pneumococcal immunization strategies for physicians. Chest. 1987 Mar;91(3):436–443. doi: 10.1378/chest.91.3.436. [DOI] [PubMed] [Google Scholar]
  9. Fedson D. S., Kessler H. A. A hospital-based influenza immunization program, 1977-78. Am J Public Health. 1983 Apr;73(4):442–445. doi: 10.2105/ajph.73.4.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Frank J. W., Henderson M., McMurray L. Influenza vaccination in the elderly: 1. Determinants of acceptance. Can Med Assoc J. 1985 Feb 15;132(4):371–375. [PMC free article] [PubMed] [Google Scholar]
  11. Frank J. W., McMurray L., Henderson M. Influenza vaccination in the elderly: 2. The economics of sending reminder letters. Can Med Assoc J. 1985 Mar 1;132(5):516-8, 521. [PMC free article] [PubMed] [Google Scholar]
  12. Hoey J. R., McCallum H. P., Lepage E. M. Expanding the nurse's role to improve preventive service in an outpatient clinic. Can Med Assoc J. 1982 Jul 1;127(1):27–28. [PMC free article] [PubMed] [Google Scholar]
  13. IPSEN J., Jr Immunization of adults against diphtheria and tetanus. N Engl J Med. 1954 Sep 16;251(12):459–466. doi: 10.1056/NEJM195409162511202. [DOI] [PubMed] [Google Scholar]
  14. Koplin A. N., Francis B. J., Martin R. J., Zimmerman S., Winegar A. Administrative costs of the influenza control program of 1976--1977 in Illinois. Med Care. 1979 Feb;17(2):201–209. doi: 10.1097/00005650-197902000-00010. [DOI] [PubMed] [Google Scholar]
  15. Larson E. B., Bergman J., Heidrich F., Alvin B. L., Schneeweiss R. Do postcard reminders improve influenza compliance? A prospective trial of different postcard "cues". Med Care. 1982 Jun;20(6):639–648. doi: 10.1097/00005650-198206000-00010. [DOI] [PubMed] [Google Scholar]
  16. Levine L., Edsall G. Tetanus toxoid: what determines reaction proneness? J Infect Dis. 1981 Oct;144(4):376–376. doi: 10.1093/infdis/144.4.376. [DOI] [PubMed] [Google Scholar]
  17. McDowell I., Newell C., Rosser W. Comparison of three methods of recalling patients for influenza vaccination. CMAJ. 1986 Nov 1;135(9):991–997. [PMC free article] [PubMed] [Google Scholar]
  18. Millian S. J., Cherubin C. E., Sherwin R., Fuerst H. T. A serologic survey of tetanus and diphtheria immunity in New York City. Arch Environ Health. 1967 Dec;15(6):776–781. doi: 10.1080/00039896.1967.10664996. [DOI] [PubMed] [Google Scholar]
  19. Newell K. W., Dueñas Lehmann A., LeBlanc D. R., Garces Osorio N. The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial. Bull World Health Organ. 1966;35(6):863–871. [PMC free article] [PubMed] [Google Scholar]
  20. Riddiough M. A., Sisk J. E., Bell J. C. Influenza vaccination. JAMA. 1983 Jun 17;249(23):3189–3195. [PubMed] [Google Scholar]
  21. Roos N. P., Shapiro E. The Manitoba longitudinal study on aging: preliminary findings on health care utilization by the elderly. Med Care. 1981 Jun;19(6):644–657. doi: 10.1097/00005650-198106000-00007. [DOI] [PubMed] [Google Scholar]
  22. Rubbo S. D. New approaches to tetanus prophylaxis. Lancet. 1966 Aug 27;2(7461):449–453. doi: 10.1016/s0140-6736(66)92766-8. [DOI] [PubMed] [Google Scholar]
  23. Ruben F. L., Nagel J., Fireman P. Antitoxin responses in the elderly to tetanus-diphtheria (TD) immunization. Am J Epidemiol. 1978 Aug;108(2):145–149. doi: 10.1093/oxfordjournals.aje.a112598. [DOI] [PubMed] [Google Scholar]
  24. Scheibel I., Bentzon M. W., Christensen P. E., Biering A. Duration of immunity to diphtheria and tetanus after active immunization. Acta Pathol Microbiol Scand. 1966;67(3):380–392. doi: 10.1111/apm.1966.67.3.380. [DOI] [PubMed] [Google Scholar]
  25. Schoenbaum S. C., McNeil B. J., Kavet J. The swine-influenza decision. N Engl J Med. 1976 Sep 30;295(14):759–765. doi: 10.1056/NEJM197609302951405. [DOI] [PubMed] [Google Scholar]
  26. TRINCA J. C. ACTIVE IMMUNIZATION AGAINST TETANUS: THE NEED FOR A SINGLE ALL-PURPOSE TOXOID. Med J Aust. 1965 Jul 17;2(3):116–120. [PubMed] [Google Scholar]
  27. Weiss B. P., Strassburg M. A., Feeley J. C. Tetanus and diphtheria immunity in an elderly population in Los Angeles County. Am J Public Health. 1983 Jul;73(7):802–804. doi: 10.2105/ajph.73.7.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. White W. G., Barnes G. M., Barker E., Gall D., Knight P., Griffith A. H., Morris-Owen R. M., Smith J. W. Reactions to tetanus toxoid. J Hyg (Lond) 1973 Jun;71(2):283–297. doi: 10.1017/s0022172400022750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. White W. G., Barnes G. M., Griffith A. H., Gall D., Barker E., Smith J. W. Duration of immunity after active immunisation against tetanus. Lancet. 1969 Jul 12;2(7611):95–96. doi: 10.1016/s0140-6736(69)92404-0. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES